05/01/2007 What’s the biggest barrier to small-tech commercialization today? Is it a lack of standards? Manufacturing or infrastructure challenges? Shortage of a qualified workforce? Intellectual property or EH&S (environmental, health, and safety) concerns?
05/01/2007 Tom Moore, a nanotechnology blogger, has set up a Machine Phase blog at http://machine-phase.blogspot.com to chronicle his nanotechnology adventures designing molecular machines using NanoEngineer-1 software from Nanorex.
05/01/2007 Air Liquide Electronics U.S. LP was recently presented with the Texas Instruments (TI) 2006 Supplier Excellence Award in recognition of its bulk gas operations services for TI over the past calendar year.
05/01/2007 When Intel (Santa Clara, CA) recently announced volume manufacturing in the second half of 2007 of a 45 nm process, something was missing: mention of a technology node.
05/01/2007 With the February announcement of a $1 million low-interest loan provided by MassDevelopment, Massachusetts’ finance and development authority, and Middlesex Savings Bank, pharmaceutical biotech contract manufacturer Hyaluron Contract Manufacturing, Inc. (HCM) is able to restructure the cleanroom and manufacturing space at its Burlington, MA-based headquarters as well as purchase backup systems for its electrical, HVAC, and mechanical infrastructure.
05/01/2007 As oil prices continue to climb and environmental concerns grow, the demand for and interest in solar power as an alternative to fossil fuel has increased dramatically.
05/01/2007 One of the most important measurements when designing an automated optical inspection (AOI) of solder bumps is bump coplanarity. Remarkably, the appropriate JEDEC specification (JESD22-B108A) defines bump coplanarity in a way that could give misleading results.
05/01/2007 The original method for counting particles was to count them visually, through a microscope, a tedious, error-prone process that has mostly been replaced by optical particle counters.
05/01/2007 By now we have all heard of, and most likely been affected by, the regulations of 21CFR Part 11. Now we’re at the point in the regulations evolution where we can draw on some practical experience and apply this to improve our facilities even further.
05/01/2007 As a pharmaceutical start-up matures, it must face an unavoidable decision: whether to develop, test, and produce its new product in-house or to outsource it.
05/01/2007 In the universe of contamination control technology, there are various products and solutions ranging from “high-tech” to “low-tech” offerings.
05/01/2007 The safety (toxicity) of nanoscale materials is largely an unknown. This is a significant knowledge void that should be considered and rectified.
05/01/2007 Flip chip on substrate assembly has been a placid technical field, with a mainstream high-volume manufacturing process carefully shepherded by production engineers towards raising yields and increasing line throughput.
